Karmanos

Komen Detroit and the Karmanos Cancer Institute Applaud Introduction of Bipartisan Cancer Alert Act

DETROIT, April 1 /PRNewswire-USNewswire/ -- Susan G. Komen Detroit Race for the Cure(R), and its local presenting sponsor, the Barbara Ann Karmanos Cancer Institute, join other Komen Affiliates and cancer-fighting organizations across the country today to applaud the introduction of the 21st Centu...

Andre Konski, M.D., M.B.A., Accepts Radiation Oncology Position at Wayne State University and the Karmanos Cancer Institute

DETROIT, Jan. 9 /PRNewswire-USNewswire/ -- Andre Konski, M.D., M.B.A., has been offered and accepted the position as Chairman of the Department of Radiation Oncology for the Wayne State University School of Medicine and Service Chief for Radiation Oncology at the Barbara Ann Karm...

J.P. McCarthy Fund Grants $250,000 to Karmanos Cancer Institute

Increasing the Awareness and Capacity of Life-Saving Cord Blood DETROIT, July 30 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Institute announced that it received a $250,000 multi-year grant from the J.P. McCarthy Fund of the Community Foundation for Southeast Michigan to benef...

McCarty Cancer Foundation Awards $50,000 Grant for Myeloma Research Program at Karmanos Cancer Institute

DETROIT, April 11 /PRNewswire-USNewswire/ -- The McCarty Cancer Foundation has awarded Jeffrey Zonder, M.D., Assistant Professor of Medicine and Oncology, Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine, a $50,000 grant for the multi-center Multiple Myeloma ...

Nominations for Outstanding Cancer Survivor Award Being Accepted by Karmanos Cancer Institute Through April 27

DETROIT, April 9 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Institute is accepting nominations for the Patricia Milner Sachs Heart of a Survivor Award. The award recognizes an outstanding cancer survivor who exemplifies caring, compassion and devotion to helping others in their...

Kroger Pink Tag Campaign Raises $137,500 for Breast Cancer Research and Awareness at Karmanos Cancer Institute

DETROIT, Jan. 23 /PRNewswire-USNewswire/ -- The Kroger Company and its participating vendors raised $137,500 during its 2007 pink tag campaign to benefit breast cancer research and awareness at the Barbara Ann Karmanos Cancer Institute. (Logo: http://www.newscom.com/cgi-bin/prnh/20071106/...

Susan G. Komen For The Cure, Karmanos Cancer Institute, Local Hospitals Call on Policymakers to Address Injustice and Unfairness in Breast Cancer Incidence and Mortality

Komen Detroit Race for the Cure Joins Nationwide Campaign to Close the Gaps that Make Breast Cancer Deadlier for Low-Income Women and Women of Color DETROIT, Oct. 23 /PRNewswire/ -- Komen Detroit Race for the Cure, physicians and executives from five of metro Detroit's top hospitals and other ...

Susan G. Komen for the Cure, Karmanos Cancer Institute, Community Leaders, Breast Cancer Survivors and Activists to Gather at Forum and Call for Action on Breast Cancer

Komen Detroit Race for the Cure to Join Nationwide Campaign Challenging U.S. to Close the Gaps in Breast Cancer Care, Survival DETROIT, Oct. 23 /PRNewswire/ -- On October 23 and 25, Komen Detroit Race for the Cure will host events to launch Metro Detroit's participation in the Komen Co...

News from Cancer

...ns have lower survival rates compared to whites. Researchers at Barbara Ann karmanos Cancer Institute, in Detroit, Michigan in Detroit sought to investigate the... Date: August 15, 2009 Contact: Patricia Ellis, Manager, Media Relations karmanos Cancer Institute, 313-576-8629 office, 313-410-3417 mobile, or ellisp@karm...

Metro Detroiters Step Up for the Susan G. Komen Detroit Race for the Cure(R), May 30

...t Comerica Park, in Detroit. The Barbara Ann karmanos Cancer Institute has been the local presenting spo... Locally presented by the Barbara Ann karmanos Cancer Institute WHEN: Saturday, May 30... the Cure(R), locally presented by the Barbara Ann karmanos Cancer Institute, is grateful for the support of i...

Karmanos in Medical Technology

International Journal of Occupational and Environmental Health Features Discovery of Asbestos-Related Pain Origin from Scientists at the Karmanos Cancer Institute in Detroit

DETROIT, July 20 /PRNewswire-USNewswire/ -- Scientists at the Barbara Ann Karmanos Cancer Institute's National Center for Vermiculite and Asbestos-Related Cancers (NCVAC) have discovered a probable reason for the unrelenting chest pain experienced in certain patients with asbestos-r...

Researchers at the Karmanos Cancer Institute in Detroit Discover Feasibility of Chemotherapy Alternative

Abstract # 6053 ORLANDO, Fla., June 1 /PRNewswire/ -- Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit presented data demonstrating the feasibility of long-term, low-dose adjuvant chemotherapy, which resulted in fewer tumor recurrences and cancer metastases in patients wit...

Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy

Abstract # 25670 ORLANDO, Fla., May 29 /PRNewswire-USNewswire/ -- The American Society of Clinical Oncology (ASCO) has selected new breast cancer research conducted at the Barbara Ann Karmanos Cancer Institute in Detroit for posting on ASCO's Web site. Karmanos' potentially ground-breaking fi...

DNA Vaccine Developed at the Karmanos Cancer Institute Fights HER2-Positive Cancers

DETROIT, Sept. 15 /PRNewswire-USNewswire/ -- Researchers at the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine have developed a HER2 DNA vaccine that has shown to be effective on drug resistant tumors in mice. The study was reported in the September 15 issu...

Expert Insights in Acute Lymphoblastic Leukemia: Current Challenges and Future Directions

...ls and is certified for nurses and pharmacists. Charles A. Schiffer, MD, Professor of Medicine at Wayne State University School of Medicine and karmanos Cancer Institute in Detroit, Michigan, serves as moderator for the panel, which includes discussion from key experts in oncology and hematology from l...

Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia

...ire-USNewswire/ -- Scientists from the Barbara Ann karmanos Cancer Institute in Detroit presented data today a...mia (AML). Dr. Ge is an Assistant Professor at the karmanos Cancer Institute and at the Wayne State Universit...low with the Developmental Therapeutics Program at karmanos Cancer Institute and Wayne State University Scho...

Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference

...ire-USNewswire/ -- Scientists from the Barbara Ann karmanos Cancer Institute in Detroit today presented data a...scom.com/cgi-bin/prnh/20071106/KARMANOSLOGO ) karmanos researchers discovered that when an FDA-approved c...or of the Translational Research Laboratory at the karmanos Cancer Institute and professor of Pharmacology at ...

Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants

...Affiliates. Two researchers from the Barbara Ann karmanos Cancer Institute and Wayne State University School...hat are invested in Wayne State University and the karmanos Cancer Institute researchers to further their rese...grants supporting the work of Robert Burack, M.D., karmanos Cancer Institute, Wayne State University; Adnan Ha...

Karmanos Doctors Urge Increased Screening for Previously Treated Lung Cancer Patients, Especially Young Women

... CHICAGO, June 1 /PRNewswire/ -- Physicians at the karmanos Cancer Institute today presented the conclusions o...table stage. Abstract No: 8048 The Barbara Ann karmanos Cancer Institute The Barbara Ann karmanos Cancer Institute in Detroit is one of 41 National ...

Karmanos Cancer Institute Researchers Show Phase I Immunotherapy with Armed T Cells Improve Overall Survival of Metastatic Breast Cancer Patients

...of BMT and Immunotherapy, Professor of Medicine at karmanos Cancer Institute and the Wayne State University Sc...adhimi, M.D., Associate Director of Immunotherapy, karmanos Cancer Institute; Cassara Skuba, B.S., Supervisor ...armanos Cancer Institute; Rebecca Sandborg, Ph.D., karmanos Cancer Institute; Ritesh Rathore, M.D., Chief of H...

Karmanos in Biological News

Vaccine against HER2-positive breast cancer offers complete protection in lab

...ivated, own-immunity to wipe out the cancer, says the study's lead investigator, Wei-Zen Wei, Ph.D., a professor of immunology and microbiology at the karmanos Cancer Institute. "The immune response against HER2-positive receptors we saw in this study is powerful, and works even in tumors that are resistan...

2 new therapies show promise for cancer patients

...sored by Genentech, also included clinical sites at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland and karmanos Cancer Institute, Detroit, Michigan. Pancreatic Cancer In the second trial, Von Hoff and colleagues showed that a novel combination of two drug...

Karmanos in Biological Technology

Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting

...anslational Research Laboratory at the Barbara Ann karmanos Cancer Institute and professor of Pharmacology at ...ssy in Paris, Mayo Clinic in Rochester, Minnesota, karmanos Cancer Institute in Detroit and University of Mar...ts of human illnesses. About the Barbara Ann karmanos Cancer Institute Located in mid-town Detroit, M...

NFGC Conducts Multi-Institutional Research Project in Ovarian Cancer

...eiping Zou , M.D., Ph.D. ( University of Michigan Comprehensive Cancer Center and Medical School ); Stephen P. Ethier , Ph.D. ( Barbara Ann karmanos Cancer Institute ); Ryan Miller , M.D., Ph.D., and Chaoying Yin , Ph.D. ( The University of North Carolina at Chapel Hill ); Mark D. Carlso...

Nereus Pharmaceuticals Initiates ADVANCE, a Randomized Phase 2 Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer

...improvement in efficacy with the addition of NPI-2358 to the standard of care," said Dr. Shirish Gadgeel, M.D., Assistant Professor at the Barbara Ann karmanos Cancer Institute in Detroit, Michigan where the first patient to enter this study was treated. "The development program for NPI-2358 has consiste...

Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer

... reported today demonstrate that XL647 has potential utility in patient populations with both mutated and wild-type EGFR," said Dr. Shirish Gadgeel of karmanos Cancer Institute at Wayne State University. "Importantly, the data highlight that patients to date appear to have milder EGFR-related side-effects -- ...